Publication:
National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease

1
0

Issued Date

2018

Resource Type

Article

File Type

application/pdf

ISSN

13205358

DOI

10.1111/nep.12922

Other identifier(s)

2-s2.0-85038085330

Rights Holder(s)

Scopus

Bibliographic Citation

Nephrology. Vol 23, No.1 (2018), p.53-59

Suggested Citation

Changsirikulchai S., Sangthawan P., Janma J., Sripaiboonkij N., Rattanamongkolgul S., Thinkhamrop B. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease. Nephrology. Vol 23, No.1 (2018), p.53-59. doi:10.1111/nep.12922 Retrieved from: https://hdl.handle.net/20.500.14740/3869

Title

National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease

Author(s)

Changsirikulchai S.
 Sangthawan P.
 Janma J.
 Sripaiboonkij N.
 Rattanamongkolgul S.
 Thinkhamrop B.

Abstract

Aim: The aim of the present study was to evaluate the achievement in controlling the risk factors of cardiovascular diseases (CVD) in Thai patients with type 2 diabetes (T2DM) and chronic kidney disease (CKD). Methods: The DMHT dataset from 2011 to 2012, which was the cross-sectional study of the national survey in Thai patients with T2DM was analyzed. Results: There were 1254 of 15 149 diabetic patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min per 1.73 m2 that had developed CVD for more than 12 months. The prevalence of CVD was 8.3%. The mean age in years was 68.2 with a standard deviation (SD) of 8.7. Males and females were 38.7 and 61.3%, respectively. The mean duration of diabetes was 8.5 (SD 0.2) years. The mean body mass index was 25.5 (SD 4.4) kg/m2. The percentage of patients with the target level of blood pressure control at ≤130/80 mm Hg was 47.1%. The percentage of patients who received angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) was 58.9%. The percentage of patients with the target level of LDL control at <70 mg/dL was 17.2%. The percentage of patients with the target level of HbA1C at 7% was 39.2%. There were 63 (5.0%) patients having recurrent CVD. Conclusions: Most Thai patients with T2DM and CKD with eGFR < 60 mL/min per 1.73 m2 could not achieve the therapeutic goals after the development of CVD. The national health policy should be planned to improve the quality of care to increase the number of patients who achieve the recommended goals. © 2016 Asian Pacific Society of Nephrology

Subject(s)

Acetylsalicylic acid
 Angiotensin receptor antagonist
 Clopidogrel
 Dipeptidyl carboxypeptidase inhibitor
 Hemoglobin A1c
 Antidiabetic agent
 Antihypertensive agent
 Antilipemic agent
 Biological marker
 Glycosylated hemoglobin
 Hemoglobin A1c protein, human
 Lipid
 Adult
 Aged
 Article
 Body mass
 Cardiovascular disease
 Chronic kidney failure
 Controlled study
 Cross-sectional study
 Disease association
 Estimated glomerular filtration rate
 Female
 Health care policy
 Human
 Major clinical study
 Male
 Non insulin dependent diabetes mellitus
 Population research
 Prevalence
 Priority journal
 Recurrent disease
 Risk factor
 Thai (people)
 Blood
 Blood pressure
 Cardiovascular disease
 Chronic kidney failure
 Drug effect
 Dyslipidemia
 Factual database
 Glomerulus filtration rate
 Glucose blood level
 Health care quality
 Health care survey
 Health status
 Hypertension
 Kidney
 Metabolism
 Middle aged
 Non insulin dependent diabetes mellitus
 Pathophysiology
 Risk assessment
 Thailand
 Time factor
 Treatment outcome
 Aged
 Antihypertensive Agents
 Biomarkers
 Blood Glucose
 Blood Pressure
 Cardiovascular Diseases
 Cross-Sectional Studies
 Databases, Factual
 Diabetes Mellitus, Type 2
 Dyslipidemias
 Female
 Glomerular Filtration Rate
 Glycated Hemoglobin A
 Health Care Surveys
 Health Status
 Humans
 Hypertension
 Hypoglycemic Agents
 Hypolipidemic Agents
 Kidney
 Lipids
 Male
 Middle Aged
 Prevalence
 Quality Indicators, Health Care
 Renal Insufficiency, Chronic
 Risk Assessment
 Risk Factors
 Thailand
 Time Factors
 Treatment Outcome

View online Resources

Research Projects

Organizational Units

Journal Issue

URI

https://hdl.handle.net/20.500.14740/3869

Collections

Scopus: Year 1983-2021

Endorsement

Review

Supplemented By

Referenced By